Featured News

3

UC study: Subcutaneous infusion pump safe, effective for...

March 18, 2024

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.

Debug Query for this

Latest News

3

UC study: Subcutaneous infusion pump safe, effective for...

March 18, 2024

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.

4

Business Courier: UC researcher pumped about breakthrough for...

March 14, 2024

Jack Rubinstein, MD, is the chief medical officer launching TRPV Pharmaceuticals, a company dedicated to advancing a therapeutic approach for cardiovascular disease. Rubinstein is also a UC professor of internal medicine at the UC College of Medicine and a pioneering researcher in the field of cardiovascular diseases.

7

UC institute picks four industry research projects for 2024

March 7, 2024

A University of Cincinnati institute selected four new projects to tackle in its second year of helping high-tech industries address their most complicated problems. UC’s Industry 4.0/5.0 Institute is dedicated to harnessing UC’s collective talent across campuses to help solve pressing issues facing businesses.

15

University of Cincinnati and Rwanda build capacity in cardiology

February 29, 2024

Rwanda faces a critical shortage of medical specialists. The University of Cincinnati's UC Rwanda Initiative has partnered with the country's ministry of health, the national University of Rwanda and the country’s teaching hospitals to develop cardiology fellowships through virtual courses and bidirectional exchange. The first two fellows visited UC for eight weeks.

Load More
Debug Query for this